Literature DB >> 20452313

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

Achia Urbach1, Ori Bar-Nur, George Q Daley, Nissim Benvenisty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20452313      PMCID： PMC3354574          DOI： 10.1016/j.stem.2010.04.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  44 in total

Review 1.  Induced pluripotent stem cells and reprogramming: seeing the science through the hype.

Authors:  Juan Carlos Izpisúa Belmonte; James Ellis; Konrad Hochedlinger; Shinya Yamanaka
Journal:  Nat Rev Genet       Date:  2009-10-27       Impact factor: 53.242

2.  FMR1 premutation allele (CGG)81 is stable in mice.

Authors:  C J Bontekoe; E de Graaff; I M Nieuwenhuizen; R Willemsen; B A Oostra
Journal:  Eur J Hum Genet       Date:  1997 Sep-Oct       Impact factor: 4.246

3.  Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

Authors:  D Wöhrle; U Salat; H Hameister; W Vogel; P Steinbach
Journal:  Am J Hum Genet       Date:  2001-07-13       Impact factor: 11.025

4.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Authors:  Bradford Coffee; Fuping Zhang; Stephanie Ceman; Stephen T Warren; Daniel Reines
Journal:  Am J Hum Genet       Date:  2002-09-13       Impact factor: 11.025

5.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

Review 6.  The promise of human induced pluripotent stem cells for research and therapy.

Authors:  Shin-ichi Nishikawa; Robert A Goldstein; Concepcion R Nierras
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Loss of FMR1 hypermethylation in somatic cell heterokaryons.

Authors:  Violeta Stoyanova; Stefano Rossetti; Leontine VAN Unen; Ben A Oostra; André T Hoogeveen
Journal:  FASEB J       Date:  2004-09-17       Impact factor: 5.191

9.  Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.

Authors:  B Coffee; F Zhang; S T Warren; D Reines
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

10.  Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos.

Authors:  Rachel Eiges; Achia Urbach; Mira Malcov; Tsvia Frumkin; Tamar Schwartz; Ami Amit; Yuval Yaron; Amir Eden; Ofra Yanuka; Nissim Benvenisty; Dalit Ben-Yosef
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633
View more
  194 in total

Review 1.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 2.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 3.  Mechanism and methods to induce pluripotency.

Authors:  Peizhe Wang; Jie Na
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

Review 4.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

5.  Evolution of iPSC disease models.

Authors:  Weiqi Zhang; Zhichao Ding; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-01       Impact factor: 14.870

6.  Cut and paste: restoring cellular function by gene correction.

Authors:  Guang-Hui Liu; Ignacio Sancho-Martinez; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

Review 7.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

Review 8.  The challenge of immunogenicity in the quest for induced pluripotency.

Authors:  Paul J Fairchild
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

Review 9.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 10.  Induced pluripotent stem cells: the new patient?

Authors:  Milena Bellin; Maria C Marchetto; Fred H Gage; Christine L Mummery
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-04       Impact factor: 94.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.